S9-3 A phase-I trial of CA9 peptide vaccines in HLA-A24 positive patients with metastatic renal cell carcinoma(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)

Hirotsugu Uemura; Shigeya Uejima; Kiyohide Fujimoto; Motoyoshi Tanaka; Yoshihiko Hirao; Kazuhiro Yoshikawa

doi:10.5980/jpnjurol.97.157

The Japanese Journal of Urology

Online ISSN : 1884-7110
Print ISSN : 0021-5287
ISSN-L : 0021-5287

S9-3 A phase-I trial of CA9 peptide vaccines in HLA-A24 positive patients with metastatic renal cell carcinoma(Symposium 9「Recent Trend of Treatment for Metastatic Renal Cell Carcinoma」)

Hirotsugu Uemura, Shigeya Uejima, Kiyohide Fujimoto, Motoyoshi Tanaka, Yoshihiko Hirao, Kazuhiro Yoshikawa

Author information

JOURNAL FREE ACCESS

2006 Volume 97 Issue 2 Pages 157-

DOI https://doi.org/10.5980/jpnjurol.97.157

Details

Article 1st page

Content from these authors

Favorites & Alerts

Corresponding author

Register with J-STAGE for free!